|[January 16, 2014]
Arrayit Corporation Participates in the International Plant and Animal Genome Conference XXII; Hosts Technology Workshop "Breakthroughs in Microarray Technology"
SUNNYVALE, Calif. --(Business Wire)--
Arrayit Corporation (OTCQB:ARYC), a life sciences and molecular
diagnostics leader, announces that the Company has showcased its
leading-edge microarray technology at the 22nd Annual
International Plant and Animal Genome Conference (PAG XXII) in San
Diego, California, held on January 11-15, 2014. PAG XXII, the largest
agricultural genomics meeting in the world, features more than 3,200
scientists, 130 exhibits, 150 workshops, 1,000 posters and 1,800
abstracts. Plant and animal genomics focuses on research and product
development based on the DNA sequence genetic blueprints of crop plants,
botanical species, livestock, and bacterial and viral pathogens that can
compromise food quality and safety.
Arrayit presented the Company's leading-edge, patented and proprietary
microarray products and services and hosted a technology workshop
entitled "Breakthroughs in Microarray Technology" thatincluded luminary
speakers, guest scientist appearances and attendee raffles.
Mark Schena, President of Arrayit Corporation, commented, "The PAG XXII
conference was very successful for us, resulting in a record number of
sales leads and providing an effective forum to present our innovative
technology and solutions to the industry. We are thrilled about the
positive reception and look forward to building on the many
relationships we developed."
About Arrayit Corporation
Arrayit utilizes its patented and proprietary microarray platform to
lead and empower the genetic, research, pharmaceutical, and diagnostic
communities through the discovery, development and manufacture of
proprietary life science technologies and consumables for disease
prevention, treatment and cure.
- Powerful Science for Life™
for more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such as
"expect", "believe", and "should". Although we believe our expectations
are reasonable, our operations involve a number of risks and
uncertainties that are beyond our control, and these statements may turn
out not to be true. Risk factors associated with our business, including
some of the facts set forth herein, are detailed in the Company's Form
10-K for the fiscal year ended December 31, 2012 and in Form 10-Q for
the quarterly period ended September 30, 2013.
[ Back To Technology News's Homepage ]